Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | MMP1 | P03956 | 1/20 | 0.38 |
| ▸ | MMP2 | P08253 | 1/20 | 0.38 |
| ▸ | MMP9 | P14780 | 1/20 | 0.38 |
| ▸ | MMP12 | P39900 | 1/20 | 0.38 |
| ▸ | TTR | P02766 | 1/20 | 0.36 |
| ▸ | BTN3A1 | O00481 | 1/20 | 0.35 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.33 |
| ▸ | FNTA | P49354 | 1/20 | 0.33 |
| ▸ | FNTB | P49356 | 1/20 | 0.33 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27200277 | 1.00 | ALOX15 (0.42) | ALOX15ALDH1A1MMP1MMP2MMP9 | |
| SCHEMBL873418 | 1.00 | ALOX15 (0.42) | ALOX15ALDH1A1MMP1MMP2MMP9 | |
| SCHEMBL18604017 | 0.83 | ALDH1A1 (0.69) | ALOX15ALDH1A1TRPV1FNTAFNTB | |
| SCHEMBL874196 | 0.83 | ALDH1A1 (0.69) | ALOX15ALDH1A1TRPV1FNTAFNTB | |
| SCHEMBL5596597 | 0.83 | ALDH1A1 (0.69) | ALOX15ALDH1A1TRPV1FNTAFNTB | |
| SCHEMBL874195 | 0.83 | ALDH1A1 (0.69) | ALOX15ALDH1A1TRPV1FNTAFNTB | |
| SCHEMBL1793466 | 0.83 | ALDH1A1 (0.69) | ALOX15ALDH1A1TRPV1FNTAFNTB | |
| SCHEMBL29165442 | 0.82 | ALDH1A1 (0.67) | ALOX15ALDH1A1TRPV1FNTAFNTB | |
| SCHEMBL5869130 | 0.82 | ALDH1A1 (0.67) | ALOX15ALDH1A1TRPV1FNTAFNTB | |
| SCHEMBL10602851 | 0.81 | ALDH1A1 (0.39) | ALOX15ALDH1A1TRPV1FNTAFNTB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-59020247-A | — | — | None | — | — | JP | disclosed |
| US-20250261684-A1 | SMOKELESS TOBACCO PRODUCT FOR ORAL USE AND SOFT CAPSULE USED THEREIN | SUNSHO PHARMACEUTICAL CO., LTD. (JP) | 2025-08-21 | — | — | US | disclosed |
| US-20250120427-A1 | CARYOPHYLLENE-CONTAINING COMPOSITION | SUNSHO PHARMACEUTICAL CO., LTD. (JP) | 2025-04-17 | — | — | US | disclosed |
| WO-2025070466-A1 | SEAMLESS CAPSULE FOR ORAL CAVITY | 森下仁丹株式会社 | 2025-04-03 | — | — | WO | disclosed |
| EP-4420534-A1 | SMOKELESS TOBACCO PRODUCT FOR ORAL USE AND SOFT CAPSULE USED THEREIN | Sunsho Pharmaceutical Co., Ltd. (JP) | 2024-08-28 | — | — | EP | disclosed |
| EP-4403170-A1 | CARYOPHYLLENE-CONTAINING COMPOSITION | Sunsho Pharmaceutical Co., Ltd. (JP) | 2024-07-24 | — | — | EP | disclosed |
| US-20240180219-A1 | SEAMLESS CAPSULE STABLY DISINTEGRABLE EVEN IN HIGH-TEMPERATURE AND HIGH-HUMIDITY ENVIRONMENT, AND METHOD FOR PRODUCING THE SAME | MORISHITA JINTAN CO., LTD. (JP) | 2024-06-06 | — | — | US | disclosed |
| EP-3888475-B1 | SEAMLESS CAPSULE, AND FILTER AND SMOKING DEVICE INCLUDING SAME | SUNSHO PHARMACEUTICAL CO LTD (JP) | 2024-04-10 | — | — | EP | disclosed |
| EP-4316472-A1 | DISINTEGRABLE SEAMLESS CAPSULE THAT IS STABLE EVEN IN HIGH-TEMPERATURE AND HIGH-HUMIDITY ENVIRONMENT, AND METHOD FOR PRODUCING SAID SEAMLESS CAPSULE | Morishita Jintan Co., Ltd. (JP) | 2024-02-07 | — | — | EP | disclosed |
| US-20230200435-A1 | CARYOPHYLLENE-CONTAINING AGENT OR COMPOSITION AND VARIOUS APPLICATIONS THEREOF | KINKI UNIVERSITY (JP) | 2023-06-29 | — | — | US | disclosed |
| US-20090087401-A1 | DEODORANT COMPOSITION | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2009-04-02 | — | — | US | disclosed |
| US-20080085251-A1 | even at a neutral to weakly acidic pH; a lactone or lactam having a mercapto group; with thioglycolic acid, thiolactic acid, cysteine, acetylcysteine, cysteamine, acylcysteamine; | RESONAC CORPORATION (JP) | 2008-04-10 | — | — | US | disclosed |
| EP-1827370-A1 | HAIR PROCESSING AGENT AND METHOD FOR PERMANENT WAVING HAIR | Showa Denko K.K. (JP) | 2007-09-05 | — | — | EP | disclosed |
| US-20060165622-A1 | Deodorant composition | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2006-07-27 | — | — | US | disclosed |
| WO-2006068276-A1 | HAIR PROCESSING AGENT AND METHOD FOR PERMANENT WAVING HAIR | SHOWA DENKO K.K. (JP) | 2006-06-29 | — | — | WO | disclosed |
| EP-1561476-A1 | DEODORANT COMPOSITION | Takasago International Corporation (JP) | 2005-08-10 | — | — | EP | disclosed |
| EP-0112394-B1 | PROCESS FOR PREPARING ANGELIC ACID OR ITS ESTER | TORAY INDUSTRIES, INC. (JP) | 1989-11-02 | — | — | EP | disclosed |
| US-4613680-A | ISOMERIZATION | TORAY INDUSTRIES, INC. (JP) | 1986-09-23 | — | — | US | disclosed |
| EP-0112394-A1 | PROCESS FOR PREPARING ANGELIC ACID OR ITS ESTER | TORAY INDUSTRIES, INC. (JP) | 1984-07-04 | — | — | EP | disclosed |
| JP-S5920247-A | ANGELIC ACID UNSATURATED ESTER AND PERFUMERY COMPOSITION CONTAINING THE SAME | TAIYO KORYO KK | 1984-02-01 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080085251-A1 | even at a neutral to weakly acidic pH; a lactone or lactam having a mercapto group; with thioglycolic acid, thiolactic acid, cysteine, acetylcysteine, cysteamine, acylcysteamine; | TST, CYSLTR1, CYSLTR2 | ALOX15 218/4885ALDH1A1 672/4885MMP1 1243/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.